Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    CASI Pharmaceuticals Inc.

    NASDAQ: CASI · Real-Time Price · USD
    2.25
    -0.01 (-0.44%)
    At close: Aug 19, 2025, 10:19 AM

    CASI Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 28.54M 33.88M 43.11M 30.17M
    Cost of Revenue
    		 17.39M 13.83M 15.83M 12.56M
    Gross Profit
    		 11.15M 20.05M 27.28M 17.61M
    Operating Income
    		 -39.62M -25.08M -26.49M -35.28M
    Interest Income
    		 539K 614K 189K 321K
    Pretax Income
    		 -38.07M -26.29M -37.43M -35.84M
    Net Income
    		 -39.26M -26.94M -39.41M -37.77M
    Selling & General & Admin
    		 41.44M 41.84M 37.77M 38.47M
    Research & Development
    		 8.92M 9.86M 16M 14.42M
    Other Expenses
    		 407K -6.57M 44K n/a
    Operating Expenses
    		 50.77M 45.13M 53.77M 52.89M
    Interest Expense
    		 871K n/a 62K n/a
    Selling & Marketing Expenses
    		 17.87M 16.45M 14.33M 14.71M
    Cost & Expenses
    		 68.16M 58.96M 69.6M 65.45M
    Income Tax Expense
    		 1.19M -81K 1.98M 1.93M
    Shares Outstanding (Basic)
    		 15.34M 13.36M 13.65M 13.61M
    Shares Outstanding (Diluted)
    		 15.34M 13.36M 13.65M 13.61M
    EPS (Basic)
    		 -2.56 -2.02 -2.89 -2.78
    EPS (Diluted)
    		 -2.56 -2.02 -2.89 -2.78
    EBITDA
    		 -34.87M -21.54M -24.07M -32.75M
    EBIT
    		 -37.2M -25.28M -26.49M -35.22M
    Depreciation & Amortization
    		 2.33M 3.74M 2.42M 3.1M

    Add to Watchlist